ResearcherSecond Hospital of Hebei Medical UniversityActive in the last 2 years
Yufeng Zhang
Matched on ORCID iD 0000-0001-8702-5291; OpenAlex author ID A5100459676. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers
Papers 4
- Exploring the biological mechanism and clinical value of perineural invasion in pancreatic cancer. First author DOI 10.1016/j.canlet.2025.217515↗
- Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance. Co-author DOI 10.1016/j.seminoncol.2025.152338↗
- Role of a novel circRNA-CGNL1 in regulating pancreatic cancer progression via NUDT4-HDAC4-RUNX2-GAMT-mediated apoptosis. Co-author DOI 10.1186/s12943-023-01923-7↗
- Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA-96. Co-author DOI 10.1111/cas.14136↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qun Chen · 2 shared papers, 2025 · strength 0.47
- Paper Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progressio… DOI 10.1016/j.seminoncol.2025.152338↗
- Paper Exploring the biological mechanism and clinical value of perineural invasion in pancreatic cancer. DOI 10.1016/j.canlet.2025.217515↗
- Hao Yuan · 2 shared papers, 2025 · strength 0.47
- Paper Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progressio… DOI 10.1016/j.seminoncol.2025.152338↗
- Paper Exploring the biological mechanism and clinical value of perineural invasion in pancreatic cancer. DOI 10.1016/j.canlet.2025.217515↗
- Kuirong Jiang · 2 shared papers, 2024–2025 · strength 0.41
- Kuirong Jiang · 1 shared paper, 2025 · strength 0.24
- Yang Wu · 1 shared paper, 2025 · strength 0.24
- Pengfei Wu · 1 shared paper, 2025 · strength 0.23
- Xumin Huang · 1 shared paper, 2025 · strength 0.23
- Xinjian Liu · 1 shared paper, 2025 · strength 0.23
- Hao Yuan · 1 shared paper, 2024 · strength 0.18
- Xinjian Liu · 1 shared paper, 2024 · strength 0.18
- Chuang Chen · 1 shared paper, 2024 · strength 0.18
- Changhong Lian · 1 shared paper, 2024 · strength 0.18
- Yuan He · 1 shared paper, 2024 · strength 0.18
- Jie Chen · 1 shared paper, 2019 · strength 0.09
- Xianghong Zhang · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.